187 related articles for article (PubMed ID: 17213470)
1. Glucose and insulin improve cardiac efficiency and postischemic functional recovery in perfused hearts from type 2 diabetic (db/db) mice.
Hafstad AD; Khalid AM; How OJ; Larsen TS; Aasum E
Am J Physiol Endocrinol Metab; 2007 May; 292(5):E1288-94. PubMed ID: 17213470
[TBL] [Abstract][Full Text] [Related]
2. Effect of BM 17.0744, a PPARalpha ligand, on the metabolism of perfused hearts from control and diabetic mice.
Aasum E; Cooper M; Severson DL; Larsen TS
Can J Physiol Pharmacol; 2005 Feb; 83(2):183-90. PubMed ID: 15791292
[TBL] [Abstract][Full Text] [Related]
3. Abnormal function and glucose metabolism in the type-2 diabetic db/db mouse heart.
Panagia M; Schneider JE; Brown B; Cole MA; Clarke K
Can J Physiol Pharmacol; 2007; 85(3-4):289-94. PubMed ID: 17612636
[TBL] [Abstract][Full Text] [Related]
4. Cardiac metabolism in mice: tracer method developments and in vivo application revealing profound metabolic inflexibility in diabetes.
Oakes ND; Thalén P; Aasum E; Edgley A; Larsen T; Furler SM; Ljung B; Severson D
Am J Physiol Endocrinol Metab; 2006 May; 290(5):E870-81. PubMed ID: 16352676
[TBL] [Abstract][Full Text] [Related]
5. A comparison between ranolazine and CVT-4325, a novel inhibitor of fatty acid oxidation, on cardiac metabolism and left ventricular function in rat isolated perfused heart during ischemia and reperfusion.
Wang P; Fraser H; Lloyd SG; McVeigh JJ; Belardinelli L; Chatham JC
J Pharmacol Exp Ther; 2007 Apr; 321(1):213-20. PubMed ID: 17202401
[TBL] [Abstract][Full Text] [Related]
6. Impact of high glucose/high insulin and dichloroacetate treatment on carbohydrate oxidation and functional recovery after low-flow ischemia and reperfusion in the isolated perfused rat heart.
Wang P; Lloyd SG; Chatham JC
Circulation; 2005 Apr; 111(16):2066-72. PubMed ID: 15824201
[TBL] [Abstract][Full Text] [Related]
7. Treatment of type 2 diabetic db/db mice with a novel PPARgamma agonist improves cardiac metabolism but not contractile function.
Carley AN; Semeniuk LM; Shimoni Y; Aasum E; Larsen TS; Berger JP; Severson DL
Am J Physiol Endocrinol Metab; 2004 Mar; 286(3):E449-55. PubMed ID: 14600074
[TBL] [Abstract][Full Text] [Related]
8. Fatty acids attenuate insulin regulation of 5'-AMP-activated protein kinase and insulin cardioprotection after ischemia.
Folmes CD; Clanachan AS; Lopaschuk GD
Circ Res; 2006 Jul; 99(1):61-8. PubMed ID: 16741157
[TBL] [Abstract][Full Text] [Related]
9. An imbalance between glycolysis and glucose oxidation is a possible explanation for the detrimental effects of high levels of fatty acids during aerobic reperfusion of ischemic hearts.
Lopaschuk GD; Wambolt RB; Barr RL
J Pharmacol Exp Ther; 1993 Jan; 264(1):135-44. PubMed ID: 8380856
[TBL] [Abstract][Full Text] [Related]
10. Chylomicron and palmitate metabolism by perfused hearts from diabetic mice.
Neitzel AS; Carley AN; Severson DL
Am J Physiol Endocrinol Metab; 2003 Feb; 284(2):E357-65. PubMed ID: 12397026
[TBL] [Abstract][Full Text] [Related]
11. A novel partial fatty acid oxidation inhibitor decreases myocardial oxygen consumption and improves cardiac efficiency in demand-induced ischemic heart.
Wu L; Belardinelli L; Fraser H
J Cardiovasc Pharmacol; 2008 Apr; 51(4):372-9. PubMed ID: 18427280
[TBL] [Abstract][Full Text] [Related]
12. Fatty acid translocase/CD36 deficiency does not energetically or functionally compromise hearts before or after ischemia.
Kuang M; Febbraio M; Wagg C; Lopaschuk GD; Dyck JR
Circulation; 2004 Mar; 109(12):1550-7. PubMed ID: 15023869
[TBL] [Abstract][Full Text] [Related]
13. Heat stress induces rapid recovery of mechanical function of ischemic fatty acid perfused hearts by stimulating glucose oxidation during reperfusion.
Broderick TL; Currie RW; Paulson DJ
Can J Physiol Pharmacol; 1997 Dec; 75(12):1273-9. PubMed ID: 9534936
[TBL] [Abstract][Full Text] [Related]
14. Absence of malonyl coenzyme A decarboxylase in mice increases cardiac glucose oxidation and protects the heart from ischemic injury.
Dyck JR; Hopkins TA; Bonnet S; Michelakis ED; Young ME; Watanabe M; Kawase Y; Jishage K; Lopaschuk GD
Circulation; 2006 Oct; 114(16):1721-8. PubMed ID: 17030679
[TBL] [Abstract][Full Text] [Related]
15. Altered metabolism causes cardiac dysfunction in perfused hearts from diabetic (db/db) mice.
Belke DD; Larsen TS; Gibbs EM; Severson DL
Am J Physiol Endocrinol Metab; 2000 Nov; 279(5):E1104-13. PubMed ID: 11052966
[TBL] [Abstract][Full Text] [Related]
16. Glucose-insulin-potassium solution improves left ventricular energetics in chronic ovine diabetes.
Ramanathan T; Morita S; Huang Y; Shirota K; Nishimura T; Zheng X; Hunyor SN
Ann Thorac Surg; 2004 Apr; 77(4):1408-14. PubMed ID: 15063275
[TBL] [Abstract][Full Text] [Related]
17. Age-dependent changes in metabolism, contractile function, and ischemic sensitivity in hearts from db/db mice.
Aasum E; Hafstad AD; Severson DL; Larsen TS
Diabetes; 2003 Feb; 52(2):434-41. PubMed ID: 12540618
[TBL] [Abstract][Full Text] [Related]
18. Metabolic effects of insulin on cardiomyocytes from control and diabetic db/db mouse hearts.
Carroll R; Carley AN; Dyck JR; Severson DL
Am J Physiol Endocrinol Metab; 2005 May; 288(5):E900-6. PubMed ID: 15632103
[TBL] [Abstract][Full Text] [Related]
19. The effects of chronic trimetazidine treatment on mechanical function and fatty acid oxidation in diabetic rat hearts.
Onay-Besikci A; Guner S; Arioglu E; Ozakca I; Ozcelikay AT; Altan VM
Can J Physiol Pharmacol; 2007 May; 85(5):527-35. PubMed ID: 17632588
[TBL] [Abstract][Full Text] [Related]
20. Beneficial effects of trimetazidine in ex vivo working ischemic hearts are due to a stimulation of glucose oxidation secondary to inhibition of long-chain 3-ketoacyl coenzyme a thiolase.
Lopaschuk GD; Barr R; Thomas PD; Dyck JR
Circ Res; 2003 Aug; 93(3):e33-7. PubMed ID: 12869392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
